Key Symposium

Technology Targeting Molecular Mechanisms

Bioelectronic medicine — the convergence of molecular medicine; neuroscience and biology; and electronics and computing to develop cures — may change the future of therapies for a wide variety of diseases. This groundbreaking discipline is aimed at interfacing electronics with nerves to specifically target the biological processes underlying disease. Bioelectronic medicine is now at the epicenter of where healthcare, technology, and science converge. A unique moment exists to characterize the challenges and opportunities facing the future of this scientific domain.

The Key Symposium included thought leaders who have the potential to explore, define, and create this new field. Session topics included: Defining Circuits, Cell Biology and Cancer, Molecular Sensing, Clinical Updates, Brain Interfaces, Processing the Future, and Funding the Field. By harnessing the power of technology spanning disciplines from microfluidics to computer processing to molecular technology, we step closer to the promise of bioelectronic medicine — to naturally reproduce a drug’s therapeutic reaction by mobilizing the body’s natural reflexes to develop effective, safe and economical alternatives to pills and injectables.

This symposium was presented by The Feinstein Institute for Medical Research, the Journal of Internal Medicine, the Royal Swedish Academy of Sciences, and The New York Academy of Sciences.